Scholarlink

<p>α-Farnesene is a valuable sesquiterpene with wide applications in cosmetics, biofuels, and pharmaceuticals. Microbial production of α-farnesene from low-cost carbon sources represents a sustainable alternative to chemical synthesis. In this study, <i>Pichia pastoris</i> was engineered to efficiently produce α-farnesene using methanol as the sole carbon source. First, the native mevalonate pathway was systematically optimized by stepwise overexpression of <i>ERG10</i>, <i>ERG13</i>, a truncated <i>HMG1</i>, and key downstream enzymes, resulting in <i>P. pastoris</i> cfn3 with α-farnesene production up to 172.1&#xa0;mg/L. Then, adaptive laboratory evolution was conducted to improve methanol tolerance, and the evolved strain <i>P. pastoris</i> evo13-4 grew more rapidly than that of <i>P. pastoris</i> cfn3. To further boost α-farnesene production, ARTP mutagenesis was used to generate numerous mutants for screening strains with high performance, among which <i>P. pastoris</i> ccg3-8 exhibited the highest production of α-farnesene up to 449.4&#xa0;mg/L. Finally, in a 5-L bioreactor, α-farnesene production with the resulting strain <i>P. pastoris</i> ccg3-8 reached 3.28&#xa0;g/L. This study presents an effective strategy for engineering <i>P. pastoris</i> for methanol-based biosynthesis of α-farnesene, providing a promising platform for the effective and sustainable production of isoprenoid compounds.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evolutionary engineering of Pichia pastoris for α-farnesene biosynthesis from methanol

  • 期刊论文

  • 发表日期：

    2025年5月19日

查看全文
  • Ziyun Gu,
  • Tiantian Chai,
  • Xiulai Chen

摘要

α-Farnesene is a valuable sesquiterpene with wide applications in cosmetics, biofuels, and pharmaceuticals. Microbial production of α-farnesene from low-cost carbon sources represents a sustainable alternative to chemical synthesis. In this study, Pichia pastoris was engineered to efficiently produce α-farnesene using methanol as the sole carbon source. First, the native mevalonate pathway was systematically optimized by stepwise overexpression of ERG10, ERG13, a truncated HMG1, and key downstream enzymes, resulting in P. pastoris cfn3 with α-farnesene production up to 172.1 mg/L. Then, adaptive laboratory evolution was conducted to improve methanol tolerance, and the evolved strain P. pastoris evo13-4 grew more rapidly than that of P. pastoris cfn3. To further boost α-farnesene production, ARTP mutagenesis was used to generate numerous mutants for screening strains with high performance, among which P. pastoris ccg3-8 exhibited the highest production of α-farnesene up to 449.4 mg/L. Finally, in a 5-L bioreactor, α-farnesene production with the resulting strain P. pastoris ccg3-8 reached 3.28 g/L. This study presents an effective strategy for engineering P. pastoris for methanol-based biosynthesis of α-farnesene, providing a promising platform for the effective and sustainable production of isoprenoid compounds.